| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Mar 7, 2024 | Y-mAbs Therapeutics, Inc. | SVP & CHIEF MEDICAL OFFICER | Sell | 26.3 | -1,711 | -4.29% | ✗ | $28.3K |
| Nov 15, 2022 | Nov 16, 2022 | Y-mAbs Therapeutics, Inc. | SVP & CMO | Buy | 90.0 | +1,195 | 38.91% | ✗ | $5.9K |
| Aug 12, 2021 | Aug 13, 2021 | Y-mAbs Therapeutics, Inc. | SVP & CMO | Buy | 91.3 | +1,374 | 80.97% | ✗ | $41.1K |
| Nov 17, 2020 | Dec 4, 2020 | Y-mAbs Therapeutics, Inc. | SVP and CMO | Buy | 95.0 | +1,697 | 115.92% | ✗ | $78.9K |